NIAAA offers funding through the Omnibus Solicitation program announcement, as well as targeted Funding Opportunity Announcements (FOAs) and several resources for additional technical assistance, commercialization R&D support, and training programs. Standard due dates are April 5, September 5, and January 5 or the next business day.

Omnibus Solicitation

Commercialization Support

Notice of Intent to Publish: Blueprint Medtech: Small Business Translator (U44)
The NIH Blueprint Medtech incubator supports innovators creating cutting-edge medical devices to diagnose or treat disorders of the nervous system through non-dilutive funds and additional developmental support including consulting, translational services and testing resources, and industry guidance.

Commercialization Readiness Pilot (CRP)
Funding and technical assistance to help develop regulatory strategy and prepare for submission for U.S. Food and Drug Administration and other agencies, as well as other support for key studies, compliance activities, and other research to advance to commercialization.

  • SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late-Stage Development - Clinical Trial Not Allowed (PAR-20-129)
  • SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance - Clinical Trial Not Allowed (PAR-20-128)
  • SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late-Stage Development - Clinical Trial Required (PAR-20-130)
  • Standard due dates apply

Innovation Corps (I-CorpsTM) at NIH Program for NIH and CDC Translational Research
An intensive 8-week entrepreneurial training course for active Phase I SBIR and STTR awardees.

  • Phase I SBIR and STTR Admin Supplement - Clinical Trial Not Allowed (PA-19-029)